We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPGI
4901
GPGI Inc
GPGI
$3.75B
$6K ﹤0.01%
1,356
-2,473
-65% -$14K
CNTX icon
4902
Context Therapeutics
CNTX
$46.5M
$6K ﹤0.01%
2,968
+2,935
+8,894% +$5.5K
COHN icon
4903
Cohen & Co
COHN
$38.7M
$6K ﹤0.01%
540
+237
+78% +$3.47K
COPX icon
4904
Global X Copper Miners ETF NEW
COPX
$7.97B
$6K ﹤0.01%
208
+121
+139% +$4.75K
CPSH icon
4905
CPS Technologies
CPSH
$83M
$6K ﹤0.01%
+1,841
New +$6.83K
CRDL
4906
Cardiol Therapeutics
CRDL
$197M
$6K ﹤0.01%
4,513
+3,323
+279% +$4.73K
BGMS
4907
Bio Green Med Solution Inc
BGMS
$5.11M
$6K ﹤0.01%
2
+1
+100% +$6.04K
MYSE
4908
Myseum.AI Inc
MYSE
$13.1M
$6K ﹤0.01%
562
+406
+260% +$6.05K
DHF
4909
BNY Mellon High Yield Strategies Fund
DHF
$176M
$6K ﹤0.01%
2,820
+320
+13% +$794
DMAC icon
4910
DiaMedica Therapeutics
DMAC
$364M
$6K ﹤0.01%
2,770
+1,102
+66% +$2.57K
DRCT icon
4911
Direct Digital Holdings
DRCT
$2.03M
$6K ﹤0.01%
+21
New +$9.38K
DSS icon
4912
DSS Inc
DSS
$5.18M
$6K ﹤0.01%
873
+601
+221% +$4.78K
ECC
4913
Eagle Point Credit Company
ECC
$512M
$6K ﹤0.01%
480
-64
-12% -$802
ECH icon
4914
iShares MSCI Chile ETF
ECH
$1.03B
$6K ﹤0.01%
+233
New +$6.35K
EDOW icon
4915
First Trust Dow 30 Equal Weight ETF
EDOW
$322M
$6K ﹤0.01%
234
-11,239
-98% -$329K
EDSA icon
4916
Edesa Biotech
EDSA
$52.3M
$6K ﹤0.01%
501
+75
+18% +$1.1K
EDZ icon
4917
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$18.5M
$6K ﹤0.01%
40
-165
-80% -$21.2K
CHRN
4918
ChronoScale Holdings
CHRN
$2.99B
$6K ﹤0.01%
+235
New +$7.47K
EMXC icon
4919
iShares MSCI Emerging Markets ex China ETF
EMXC
$24.7B
$6K ﹤0.01%
+127
New +$6.76K
ESOA icon
4920
Energy Services of America
ESOA
$233M
$6K ﹤0.01%
+2,891
New +$7.13K
FDL icon
4921
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.98B
$6K ﹤0.01%
161
+27
+20% +$1.01K
FGM icon
4922
First Trust Germany AlphaDEX Fund
FGM
$98.4M
$6K ﹤0.01%
+167
New +$6.71K
FOCT icon
4923
FT Vest US Equity Buffer ETF October
FOCT
$1.19B
$6K ﹤0.01%
+200
New +$6.6K
GBR icon
4924
New Concept Energy
GBR
$3.73M
$6K ﹤0.01%
4,467
+3,995
+846% +$9.03K
CBIO
4925
Crescent Biopharma
CBIO
$618M
$6K ﹤0.01%
96
+76
+380% +$5.63K
195 196
197
198 199

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.